Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,627 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00071942 | Vaccine Therapy in Treating Patients With Metastatic Breast Cancer | terminated | Phase 1 | 22 | National Cancer Institute (NCI)NIH | 1 | Dec 11, 2013 | clinicaltrials |
| NCT00416130 | Clinical Trial of SAHA in Patients With Breast Cancer | unknown | Phase 1 / Phase 2 | 49 | National University Hospital, SingaporeOTHER | 1 | Dec 10, 2013 | clinicaltrials |
| NCT00066547 |
| Monoclonal Antibody Therapy in Treating Women With Locally Advanced or Metastatic Breast Cancer Previously Treated With Combination Chemotherapy |
| unknown |
| Phase 1 / Phase 2 |
| — |
| Jonsson Comprehensive Cancer CenterOTHER |
| 1 |
| Dec 4, 2013 |
| clinicaltrials |
| NCT00496665 | ZD6474 (Zactima) and Metronomic Chemotherapy in Advanced Breast Cancer | completed | Phase 1 | 25 | Dana-Farber Cancer InstituteOTHER | 1 | Nov 18, 2013 | clinicaltrials |
| NCT00316875 | Lapatinib and Doxorubicin Hydrochloride Liposome in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 | 23 | Northwestern UniversityOTHER | 1 | Nov 8, 2013 | clinicaltrials |
| NCT00002465 | High-Dose Megestrol in Treating Patients With Metastatic Breast Cancer, Endometrial Cancer, or Mesothelioma | unknown | Phase 1 / Phase 2 | — | St. Vincent Medical Center - Los AngelesOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00003432 | Immunotherapy in Treating Patients With Metastatic Breast Cancer | terminated | Phase 1 / Phase 2 | 4 | Duke UniversityOTHER | 1 | Nov 6, 2013 | clinicaltrials |
| NCT00290732 | Liposomal Doxorubicin Before Mastectomy in Treating Women With Invasive Breast Cancer | completed | Phase 1 | 20 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Oct 31, 2013 | clinicaltrials |
| NCT00004156 | Vaccine Therapy in Treating Patients With Breast Cancer | completed | Phase 1 | 45 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 30, 2013 | clinicaltrials |
| NCT01060514 | Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast Cancer | terminated | Phase 1 | 8 | Northwestern UniversityOTHER | 1 | Oct 30, 2013 | clinicaltrials |
| NCT01230671 | The Physical and Psychological Benefits of Yoga and Breast Cancer | completed | Phase 1 | 80 | Dr. Sarkis MeterissianOTHER | 1 | Oct 25, 2013 | clinicaltrials |
| NCT00726180 | Use of Trastuzumab to Induce Increased ER Expression in ER-negative/Low, Her-2/Neu Positive Breast Cancer | terminated | Phase 1 / Phase 2 | 1 | University of Michigan Rogel Cancer CenterOTHER | 1 | Oct 15, 2013 | clinicaltrials |
| NCT00031681 | 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007) | completed | Phase 1 | 41 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT01208441 | RO4929097 and Letrozole in Treating Post-Menopausal Women With Hormone Receptor-Positive Stage II or Stage III Breast Cancer | terminated | Phase 1 | 28 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT01705340 | Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery | terminated | Phase 1 | 60 | National Cancer Institute (NCI)NIH | 1 | Sep 30, 2013 | clinicaltrials |
| NCT00002616 | Biological Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer | unknown | Phase 1 | 36 | University of Illinois at ChicagoOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00009763 | Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer | unknown | Phase 1 | — | University of California, DavisOTHER | 1 | Sep 20, 2013 | clinicaltrials |
| NCT00003412 | Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation | unknown | Phase 1 | 35 | Beth Israel Deaconess Medical CenterOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00983424 | Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer | completed | Phase 1 | 14 | Northwestern UniversityOTHER | 1 | Sep 16, 2013 | clinicaltrials |
| NCT01931943 | A Phase Ib Study of Selatinib Ditosilate Tablets in Patients With Advanced Breast Cancer | unknown | Phase 1 | 24 | Qilu Pharmaceutical Co., Ltd.INDUSTRY | 1 | Aug 30, 2013 | clinicaltrials |
| NCT00014456 | Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 35 | Dartmouth-Hitchcock Medical CenterOTHER | 1 | Aug 28, 2013 | clinicaltrials |
| NCT01240928 | MK-2206+Endocrine Therapy in Patients With Hormone Receptor-Positive Breast Cancer | withdrawn | Phase 1 | 0 | Vanderbilt-Ingram Cancer CenterOTHER | 0 | Aug 20, 2013 | clinicaltrials |
| NCT00931450 | Sunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast Cancer | unknown | Phase 1 / Phase 2 | 70 | Institut Català d'OncologiaOTHER | 1 | Aug 12, 2013 | clinicaltrials |
| NCT00003920 | Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer | unknown | Phase 1 | 18 | University of California, DavisOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00017537 | Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer | withdrawn | Phase 1 | 0 | University of Alabama at BirminghamOTHER | 0 | Aug 5, 2013 | clinicaltrials |
| NCT00574301 | Percutaneous Removal and Margin Ablation for Breast Cancer | completed | Phase 1 / Phase 2 | 32 | University of ArkansasOTHER | 1 | Jul 25, 2013 | clinicaltrials |
| NCT00002873 | Radiation Therapy in Treating Women With Stage I or Stage II Breast Cancer | completed | Phase 1 / Phase 2 | — | Radiation Therapy Oncology GroupNETWORK | 2 | Jul 19, 2013 | clinicaltrials |
| NCT00039052 | Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer | completed | Phase 1 | — | Neurocrine BiosciencesINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00004174 | Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer | completed | Phase 1 | 30 | Northwestern UniversityOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT01614184 | Fluorescein for Sentinel Lymph Node Biopsy (SLNB) in Breast Cancer | withdrawn | Phase 1 / Phase 2 | 0 | University of UtahOTHER | 0 | Jul 10, 2013 | clinicaltrials |
| NCT00003103 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00096057 | Monoclonal Antibody HuHMFG1 in Treating Women With Locally Advanced or Metastatic Breast Cancer | completed | Phase 1 | 24 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00004065 | Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 24, 2013 | clinicaltrials |
| NCT00019916 | Vaccine Therapy Plus Interleukin-2 in Treating Women With Stage IV, Recurrent, or Progressive Breast or Ovarian Cancer | completed | Phase 1 / Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 20, 2013 | clinicaltrials |
| NCT00004925 | Liposomal Doxorubicin and Trastuzumab in Treating Women With Locally Advanced, Inflammatory, or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00049608 | Gemcitabine Combined With Mistletoe in Treating Patients With Advanced Solid Tumors | terminated | Phase 1 | 51 | National Center for Complementary and Integrative Health (NCCIH)NIH | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00674791 | Study of Cancer Peptides Vaccine Plus GM-CSF as Adjuvant Treatment for High Risk (TXN2-3M0) or Metastatic Breast Cancer With No Evidence of Disease | completed | Phase 1 | 13 | Duke UniversityOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT01880385 | Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer(Beva) | unknown | Phase 1 | 30 | Association Tunisienne de lutte Contre le CancerOTHER | 1 | Jun 19, 2013 | clinicaltrials |
| NCT00020332 | Docetaxel and Flavopiridol in Treating Patients With Locally Advanced or Metastatic Breast Cancer | completed | Phase 1 / Phase 2 | — | National Cancer Institute (NCI)NIH | 1 | Jun 17, 2013 | clinicaltrials |
| NCT00028535 | Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors | completed | Phase 1 | 18 | National Cancer Institute (NCI)NIH | 1 | Jun 4, 2013 | clinicaltrials |
| NCT00020852 | Cryosurgery in Treating Women With Breast Lesions | completed | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00659568 | Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma | completed | Phase 1 | 28 | London Health Sciences CentreOTHER | 1 | May 30, 2013 | clinicaltrials |
| NCT00099008 | Genistein in Preventing Breast or Endometrial Cancer in Healthy Postmenopausal Women | completed | Phase 1 | 30 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | May 21, 2013 | clinicaltrials |
| NCT01219907 | Ex Vivo-Expanded HER2-Specific T Cells and Cyclophosphamide After Vaccine Therapy in Treating Patients With HER2-Positive Stage IV Breast Cancer | withdrawn | Phase 1 | 0 | University of WashingtonOTHER | 1 | May 17, 2013 | clinicaltrials |
| NCT00007891 | Radiolabeled Monoclonal Antibody Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer | completed | Phase 1 | — | Cancer Research Institute of Contra CostaOTHER | 1 | May 15, 2013 | clinicaltrials |
| NCT00060138 | Monoclonal Antibody Compared With Zoledronate in Treating Women With Breast Cancer and Bone Metastases | completed | Phase 1 / Phase 2 | — | Chugai PharmaceuticalINDUSTRY | 1 | May 15, 2013 | clinicaltrials |
| NCT00381173 | A Study of ZYC300 Administered With Cyclophosphamide Pre-Dosing | completed | Phase 1 | 22 | Eisai Inc.INDUSTRY | 1 | May 14, 2013 | clinicaltrials |
| NCT00245024 | Sulindac in Preventing Breast Cancer in Women at High Risk for Breast Cancer | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | May 3, 2013 | clinicaltrials |
| NCT00006368 | Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer | completed | Phase 1 | 60 | Novartis PharmaceuticalsINDUSTRY | 1 | May 1, 2013 | clinicaltrials |
| NCT00903214 | Riluzole in Women With Stage I, Stage II, or Stage IIIA Breast Cancer | withdrawn | Phase 1 | 0 | Barbara Ann Karmanos Cancer InstituteOTHER | 0 | Apr 29, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Dec 11, 2013source: clinicaltrials